Work

Ibrutinib Alone and in Combination with Dexamethasone and Carfilzomib Significantly Inhibits Cell Proliferation in Primary Mediastinal B-Cell Lymphoma (PMBL): Ibrutinib May be a Future Targeted Agent in Combination Therapy in Patients with PMBL

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.4852.4852

Authors: Sanghoon Lee, Changhong Yin, Janet Ayello, Erin Morris, Lauren Harrison, Carmella van de Ven, Matthew J. Barth, Rodney R. Miles, Paul J. Galardy, Stanton Goldman, Megan S Lim, Michelle L. Hermiston, Linda McAllister-Lucas, Lisa Giulino-Roth, Sherrie L. Perkins, Mitchell S. Cairo

Institutions: New York Medical College, Roswell Park Comprehensive Cancer Center, University of Utah, Mayo Clinic, Medical City Children's Hospital, University of Michigan, Michigan Medicine, University of California, San Francisco, University of Pittsburgh, Memorial Sloan Kettering Cancer Center, ARUP Institute for Clinical and Experimental Pathology

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2548785484

FWCI: 0.23

Cites:

Cited by: 1

Related to: 10